The new anti-interleukin-1beta monoclonal antibody, gevokizumab, reduces hs-crp in subjects with type 2 diabetes mellitus

被引:0
|
作者
Feldstein, J. [1 ]
Davis, S. N. [2 ]
Zayed, H. [1 ]
Whitmore, J. [1 ]
机构
[1] XOMA LLC, Berkeley, CA USA
[2] Univ Maryland, Baltimore, MD 21201 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1015 / 1015
页数:1
相关论文
共 50 条
  • [42] Association of IA-2 antibody with HLA phenotypes and autoimmune thyroid disease (AITD) in Japanese subjects with type 1 diabetes mellitus
    Nakamura, T
    Nagasaka, S
    Kusaka, I
    Ishikawa, SE
    Saito, T
    DIABETES, 2001, 50 : A37 - A37
  • [43] Anti-CD38 autoantibodies: New markers of beta cell autoimmunity in type 1 and type 2 diabetes
    Mallone, R
    Ortolan, E
    Volante, M
    Pinach, S
    Boscolo, D
    Cavallo-Perin, P
    Malavasi, F
    DIABETOLOGIA, 2001, 44 : A74 - A74
  • [44] Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody
    Bednar, Kyle J.
    Tsukamoto, Hiroki
    Kachapati, Kritika
    Ohta, Shoichiro
    Wu, Yuehong
    Katz, Jonathan D.
    Ascherman, Dana P.
    Ridgway, William M.
    DIABETES, 2015, 64 (10) : 3614 - 3626
  • [45] Association of anti-GAD antibody and HbA1c in type 2 diabetes mellitus patients from a Korean tertiary hospital
    Hwang, Sang Hyun
    Rim, John Hoon
    Kang, Won Jun
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [46] New-Onset Type 1 Diabetes Mellitus and Anti-Aquaporin-4 Antibody Positive Optic Neuritis Associated with Type 1 Interferon Therapy for Chronic Hepatitis C
    Kawazoe, Tomoya
    Araki, Manabu
    Lin, Youwei
    Ogawa, Masafumi
    Okamoto, Tomoko
    Yamamura, Takashi
    Wakakura, Masato
    Murata, Miho
    INTERNAL MEDICINE, 2012, 51 (18) : 2625 - 2629
  • [47] Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: A randomized, triple-blind, placebo-controlled clinical trial
    Koujan, Soraiya Ebrahimpour
    Gargari, Bahram Pourghassem
    Mobasseri, Majid
    Valizadeh, Hadi
    Asghari-Jafarabadi, Mohammad
    PHYTOMEDICINE, 2015, 22 (02) : 290 - 296
  • [48] Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus
    Timper, Katharina
    Seelig, Eleonora
    Tsakiris, Dimitrios A.
    Donath, Marc Y.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (07) : 955 - 960
  • [49] Multi-center intervention study on glycohemoglobin (HbA1c) and serum, high-sensitivity CRP (hs-CRP) after local anti-infectious periodontal treatment in type 2 diabetic patients with periodontal disease
    Katagiri, S.
    Nitta, H.
    Nagasawa, T.
    Uchimura, I.
    Izumiyama, H.
    Inagaki, K.
    Kikuchi, T.
    Noquchi, T.
    Kanazawa, M.
    Matsuo, A.
    Chiba, H.
    Nakamura, N.
    Kanamura, N.
    Inoue, S.
    Ishikawa, I.
    Izumi, Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (03) : 308 - 315
  • [50] Gingival crevicular fluid levels of human beta-defensins 1 and 3 in subjects with periodontitis and/or type 2 diabetes mellitus: a cross-sectional study
    Ertugrul, A. S.
    Dikilitas, A.
    Sahin, H.
    Alpaslan, N.
    Bozoglan, A.
    Tekin, Y.
    JOURNAL OF PERIODONTAL RESEARCH, 2013, 48 (04) : 475 - 482